Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Down 31.8% in June

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) was the target of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 149,100 shares, a decrease of 31.8% from the May 31st total of 218,700 shares. Based on an average daily volume of 14,209,400 shares, the short-interest ratio is currently 0.0 days.

Therapeutic Solutions International Stock Performance

Shares of TSOI stock remained flat at $0.00 during trading on Friday. 6,819,044 shares of the company were exchanged, compared to its average volume of 20,870,732. Therapeutic Solutions International has a 12 month low of $0.00 and a 12 month high of $0.00.

Therapeutic Solutions International Company Profile

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.